The selective formation of C-C and C═C bonds is fundamentally important in pharmaceutical synthesis and materials science. Herein, the ligand-controlled chemoselectivity of the Mn-catalyzed coupling of benzyl alcohol (BnOH) with a phosphorus ylide for the C-C or C═C product was theoretically investigated through DFT and DLPNO-CCSD(T) calculations. For the PNP-supported catalyst 1A ([Mn(CO)₂(N(C₂H₄PiPr₂)₂)]), BnOH undergoes dehydrogenation via Mn-N cooperation (ΔG≠ = 25.5 kcal/mol) to yield benzaldehyde and the Mn-hydride intermediate 4A. Benzaldehyde subsequently reacts with the ylide via Wittig olefination to generate an E-alkene, which is selectively hydrogenated by 4A (ΔG≠ = 29.5 kcal/mol) to afford the C-C product. In contrast, the NNP-ligated catalyst favors C═C bond formation, as the corresponding Mn-hydride 4B undergoes H₂ evolution (ΔG≠ = 31.2 kcal/mol) rather than alkene hydrogenation (ΔG≠ = 33.1 kcal/mol). This divergent reactivity originates from the lower hydride dissociation energy and greater steric hindrance of the NNP ligand, which collectively suppress alkene hydrogenation and promote H₂ release. Guided by these insights, catalyst 1A was modified by replacing iPr with bulkier tBu groups to construct 1C, which shifts the chemoselectivity toward the C═C product exclusively. These findings emphasize the crucial role of ligand design in steering the chemoselectivity in base-metal-catalyzed transformations.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: